Worldwide, also known as Worldwide Clinical Trials, is a prominent player in the global clinical research industry, headquartered in the United States. Founded in 2007, the company has established a strong presence across North America, Europe, and Asia, providing comprehensive services in drug development and clinical trial management. Specialising in Phase I-IV clinical trials, Worldwide is recognised for its innovative approach and commitment to quality, offering unique solutions that streamline the research process. The company’s core services include clinical trial design, patient recruitment, and data management, all tailored to meet the specific needs of its clients. With a reputation for excellence, Worldwide has achieved significant milestones, positioning itself as a trusted partner for pharmaceutical and biotechnology companies. Its dedication to advancing medical research continues to set it apart in a competitive market.
How does Worldwide's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Worldwide's score of 23 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
As of the latest available data, Worldwide has not reported any carbon emissions figures, indicating a lack of specific emissions data for the most recent year. Consequently, there are no absolute emissions numbers to analyse, including Scope 1, 2, or 3 emissions. In terms of climate commitments, Worldwide has not established any documented reduction targets or initiatives, nor does it appear to have any climate pledges in place. This absence of data suggests that the organisation may still be in the early stages of developing a comprehensive climate strategy or may rely on broader industry standards without specific commitments. Given the current context, it is essential for Worldwide to consider setting measurable targets and engaging in initiatives that align with global climate goals, particularly as the urgency for corporate climate action continues to grow.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Worldwide has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
